{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"castleman-kojima-disease","columns":[{"gene":"","key":"population-e7d96bad56a0ed41bd69","label":"TAFRO syndrome","mondoId":"MONDO:0018702","onsetQualifier":null,"originColumnKey":"MONDO:0018702/ORPHA:457077","originalViews":[{"key":"MONDO:0018702/ORPHA:457077","label":"TAFRO syndrome","scopeLabel":"ORPHA:457077","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["037c31e57f11299792c9079dfcf078133f9b4ac0adfe1721da8880bc88b8c2d8","0ab7bf2ba4004ed0da8f7dcfd07469f7b0d5cef1664364c719d45730eadf1cfd","11717d4bcbb61e094bcf8ab1119209e4cf50768d0bb9febe13d7ef4ec9a11211","119ac2c0fad631f36ff23d6d22612adcc18aa717f85c39e15f1428c34e8cd441","263830a313c4659431d00f8d728081fd3fd19a5a806e9ef2d46224a2be96b1b5","48c64250a2d6f3471320c75a4df7e0db24c5e7c8f4d76c0aa24eecba6668a476","5477e091f3129214bb5b34b6e5a1fc53ca3f569e5ea3a4fc734262516fe60e2e","59e2c3f665f6aaa58ad921673b6b68ac51c84cf5566f67be0333a67097f68013","61a8ea8a9a73ba7a187223035c603d8f20833c7811ce3ddcb9c7e8e74eb34e14","672f49d5b5bba04947a345d610c84d70504a999843b94d0428002e86fa2a6cff","6f9a5dcee03dd45507bbff299259d622ede32bf285061379881e5d96a9cb0a43","71f0773c0ee39dd9a2c1d40a3f5c0ac30529f2078c8cac2f7a34b2846dc4567e","759a3637c1c27d761861a8e0f91e65ed801977d69e754179eea4ddf3ccc789e9","96db5286f9c6dbfd56a7823ea1cc748ffa729fbe3e59c8599850cf8f51e9d250","a31769127c27329f420c54168a535a52d96ed8b38232dfd7c3acd5662f1fa6c9","a3388e3a1d606c9f85d28ecfeb0bbb2e1519cea8cf2cba0acace3ae5ffc808e2","aea766f0dd44f97e320c82f097e6c4b2552b8901e651ff490e9564209d72f781","af659dbf6715cde07d3e6ab2f96f7e7667dd04ec788b792072f604da93afed9e","b9314e144bd13bd11b41f3272d9f96a58dc999f70ee8135197f00e222fcdc4ff","bdc93c941b3c8f26cbca9ef0004cdffbe9d2885c881557cf7444c242f5da1659","c7825fd510e237be65e9e7133171fd27a2ab85441a7eef665172daf5ec708ef9","dd4552317ed307f74be2cbc58f204b73d1be642c7482ec5694350ba749decff0","e4b51629d713a76ea6cd34cceac5c2466caa57fc93fe126b03a45864df7474e7","ea2f10ea8501fc8c45dfe976712641f6068d51044ff5816a96813962315eb834","eeb4726f762b4c498802ce4eb3d71760fb4685f498d59d4075a14a9e2267d52e"],"recordQualifiers":{},"scopeLabel":"ORPHA:457077","sourceIds":["ORPHA:457077"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-e7d96bad56a0ed41bd69"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0012050","HP:0001903","HP:0001541","HP:0002960","HP:0003155","HP:0011227","HP:0031052"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":25,"sourceGroups":{"orphanet":25}},"features":[{"hpoId":"HP:0012050","label":"Anasarca","primary":true},{"hpoId":"HP:0001903","label":"Anemia","primary":true},{"hpoId":"HP:0001541","label":"Ascites","primary":true},{"hpoId":"HP:0002960","label":"Autoimmunity","primary":true},{"hpoId":"HP:0003155","label":"Elevated circulating alkaline phosphatase concentration","primary":true},{"hpoId":"HP:0011227","label":"Elevated circulating C-reactive protein concentration","primary":true},{"hpoId":"HP:0031052","label":"Elevated vascular endothelial growth factor level","primary":true},{"hpoId":"HP:0001945","label":"Fever","primary":false},{"hpoId":"HP:0012156","label":"Hemophagocytosis","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0001433","label":"Hepatosplenomegaly","primary":false},{"hpoId":"HP:0030783","label":"Increased circulating interleukin 6 concentration","primary":false},{"hpoId":"HP:0005513","label":"Increased megakaryocyte count","primary":false},{"hpoId":"HP:0001974","label":"Increased total leukocyte count","primary":false},{"hpoId":"HP:0002716","label":"Lymphadenopathy","primary":false},{"hpoId":"HP:0011974","label":"Myelofibrosis","primary":false},{"hpoId":"HP:0002664","label":"Neoplasm","primary":false},{"hpoId":"HP:0002202","label":"Pleural effusion","primary":false},{"hpoId":"HP:0032288","label":"Polyclonal elevation of circulating IgG concentration","primary":false},{"hpoId":"HP:0032262","label":"Pulmonary tuberculosis","primary":false},{"hpoId":"HP:0045041","label":"Reduced circulating lactate dehydrogenase concentration","primary":false},{"hpoId":"HP:0000083","label":"Renal insufficiency","primary":false},{"hpoId":"HP:0031691","label":"Severe viral infection","primary":false},{"hpoId":"HP:0001744","label":"Splenomegaly","primary":false},{"hpoId":"HP:0001873","label":"Thrombocytopenia","primary":false}],"ledeHtml":"A clinicopathologic variant of multicentric Castleman&#x27;s disease characterized by thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly","mondoId":"MONDO:0018702","node":{"canonicalSlug":"castleman-kojima-disease","comparisons":[{"documentSha256":"832610b9a591e827cac31904a63f381b331bccba9d619ef9fa4165bd808c7b30","key":"legacy-castleman-kojima-disease","kind":"legacy","label":"Castleman-Kojima disease","memberIds":["MONDO:0018702"],"mondoId":"MONDO:0018702","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/castleman-kojima-disease.832610b9a591e827cac31904a63f381b331bccba9d619ef9fa4165bd808c7b30.json"},{"documentSha256":"2a8dea17ad3684543a532636b1570fe11ac8e4f110741a3c752dca9ca9c3d80a","key":"expanded-autoimmune-lymphoproliferative","kind":"expanded","label":"autoimmune lymphoproliferative syndrome","memberIds":["MONDO:0011158","MONDO:0011383","MONDO:0011804","MONDO:0013767","MONDO:0014493","MONDO:0017979","MONDO:0018702","MONDO:1060194","MONDO:8000023","MONDO:8000024"],"mondoId":"MONDO:0017979","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-2a8dea17ad3684543a53.2a8dea17ad3684543a532636b1570fe11ac8e4f110741a3c752dca9ca9c3d80a.json"},{"documentSha256":"bc25e36f9408021a84335602bbb8476e3b27ed3e9f612c009327b98a7cf77201","key":"expanded-castleman-disease","kind":"expanded","label":"Castleman disease","memberIds":["MONDO:0015564","MONDO:0018702","MONDO:0019752","MONDO:0019753","MONDO:0019754","MONDO:0035838"],"mondoId":"MONDO:0015564","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-bc25e36f9408021a8433.bc25e36f9408021a84335602bbb8476e3b27ed3e9f612c009327b98a7cf77201.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"Castleman-Kojima disease","paragraphs":["A clinicopathologic variant of multicentric Castleman's disease characterized by thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly"],"scope":"exact","source":"MONDO","upstream":"PMID:23801135","url":"https://monarchinitiative.org/MONDO:0018702"},"ownColumnKeys":["population-e7d96bad56a0ed41bd69"],"publication":"published","relationships":[{"kind":"parent","label":"autoimmune lymphoproliferative syndrome","mondoId":"MONDO:0017979","slug":"autoimmune-lymphoproliferative"},{"kind":"parent","label":"idiopathic multicentric Castleman disease","mondoId":"MONDO:0035838","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/21902"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"037c31e57f11299792c9079dfcf078133f9b4ac0adfe1721da8880bc88b8c2d8","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0ab7bf2ba4004ed0da8f7dcfd07469f7b0d5cef1664364c719d45730eadf1cfd","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011974","is_excluded":false,"label":"Myelofibrosis","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"11717d4bcbb61e094bcf8ab1119209e4cf50768d0bb9febe13d7ef4ec9a11211","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001744","is_excluded":false,"label":"Splenomegaly","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"119ac2c0fad631f36ff23d6d22612adcc18aa717f85c39e15f1428c34e8cd441","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001873","is_excluded":false,"label":"Thrombocytopenia","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"263830a313c4659431d00f8d728081fd3fd19a5a806e9ef2d46224a2be96b1b5","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003155","is_excluded":false,"label":"Elevated circulating alkaline phosphatase concentration","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"48c64250a2d6f3471320c75a4df7e0db24c5e7c8f4d76c0aa24eecba6668a476","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001903","is_excluded":false,"label":"Anemia","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5477e091f3129214bb5b34b6e5a1fc53ca3f569e5ea3a4fc734262516fe60e2e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0045041","is_excluded":false,"label":"Reduced circulating lactate dehydrogenase concentration","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"59e2c3f665f6aaa58ad921673b6b68ac51c84cf5566f67be0333a67097f68013","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001433","is_excluded":false,"label":"Hepatosplenomegaly","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"61a8ea8a9a73ba7a187223035c603d8f20833c7811ce3ddcb9c7e8e74eb34e14","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011227","is_excluded":false,"label":"Elevated circulating C-reactive protein concentration","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"672f49d5b5bba04947a345d610c84d70504a999843b94d0428002e86fa2a6cff","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002202","is_excluded":false,"label":"Pleural effusion","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6f9a5dcee03dd45507bbff299259d622ede32bf285061379881e5d96a9cb0a43","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001974","is_excluded":false,"label":"Increased total leukocyte count","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"71f0773c0ee39dd9a2c1d40a3f5c0ac30529f2078c8cac2f7a34b2846dc4567e","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0032262","is_excluded":true,"label":"Pulmonary tuberculosis","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"759a3637c1c27d761861a8e0f91e65ed801977d69e754179eea4ddf3ccc789e9","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002664","is_excluded":true,"label":"Neoplasm","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"96db5286f9c6dbfd56a7823ea1cc748ffa729fbe3e59c8599850cf8f51e9d250","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001945","is_excluded":false,"label":"Fever","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a31769127c27329f420c54168a535a52d96ed8b38232dfd7c3acd5662f1fa6c9","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0030783","is_excluded":false,"label":"Increased circulating interleukin 6 concentration","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a3388e3a1d606c9f85d28ecfeb0bbb2e1519cea8cf2cba0acace3ae5ffc808e2","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012050","is_excluded":false,"label":"Anasarca","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"aea766f0dd44f97e320c82f097e6c4b2552b8901e651ff490e9564209d72f781","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031052","is_excluded":false,"label":"Elevated vascular endothelial growth factor level","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"af659dbf6715cde07d3e6ab2f96f7e7667dd04ec788b792072f604da93afed9e","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000083","is_excluded":false,"label":"Renal insufficiency","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b9314e144bd13bd11b41f3272d9f96a58dc999f70ee8135197f00e222fcdc4ff","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0012156","is_excluded":true,"label":"Hemophagocytosis","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bdc93c941b3c8f26cbca9ef0004cdffbe9d2885c881557cf7444c242f5da1659","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0005513","is_excluded":false,"label":"Increased megakaryocyte count","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"c7825fd510e237be65e9e7133171fd27a2ab85441a7eef665172daf5ec708ef9","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0031691","is_excluded":true,"label":"Severe viral infection","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"dd4552317ed307f74be2cbc58f204b73d1be642c7482ec5694350ba749decff0","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002960","is_excluded":true,"label":"Autoimmunity","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e4b51629d713a76ea6cd34cceac5c2466caa57fc93fe126b03a45864df7474e7","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0032288","is_excluded":true,"label":"Polyclonal elevation of circulating IgG concentration","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ea2f10ea8501fc8c45dfe976712641f6068d51044ff5816a96813962315eb834","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001541","is_excluded":false,"label":"Ascites","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"eeb4726f762b4c498802ce4eb3d71760fb4685f498d59d4075a14a9e2267d52e","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:457077","disease_name":"TAFRO syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002716","is_excluded":false,"label":"Lymphadenopathy","onset_id":null,"reference":"ORPHA:457077","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018702\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>PMID:23801135</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A clinicopathologic variant of multicentric Castleman&#x27;s disease characterized by thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018702\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"castleman-kojima-disease","sourceDocuments":[{"name":"MONDO: Castleman-Kojima disease","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0018702"}],"sourceNote":"","synonyms":["TAFRO syndrome","thrombocytopenia-anasarca-fever-renal insufficiency-organomegaly syndrome"],"takeawayHtml":"","title":"Castleman-Kojima disease"},"schemaVersion":1}
